Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,495.00    35.00 (2.40%)
Bid:
1,539.00
Ask:
1,485.00
Spread: -54.00 (-3.509%)
Market Cap: £3.10b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Blocklisting Interim Review

6 Oct 2014 15:58

RNS Number : 5739T
Hikma Pharmaceuticals Plc
06 October 2014
 



 

Block Listing Six Monthly Return

 

Information provided on this form must be typed or printed electronically and provided to an RIS.

 

Date: 6 October 2014

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

&

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

&

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

Period of return

From:

1 April 2014

To:

30 September 2014

Balance of unallotted securities under scheme(s) from previous return:

SOP: 967,900 ordinary shares of 10 pence

LTIP: 400,050 ordinary shares of 10 pence

MIP: 378,360 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 38,200 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 356,752 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 929,700 ordinary shares of 10 pence

LTIP: 400,050 ordinary shares of 10 pence

MIP: 21,608 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

 

 

 

Stock Option Plan ("SOP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

967,900

Blocklisting return 01/04/2014

10/04/2014

0

8,500

959,400

25/04/2014

0

2,500

956,900

23/05/2014

0

1,000

955,900

12/06/2014

0

2,500

953,400

12/06/2014

0

1,700

951,700

21/08/2014

0

6,000

945,700

21/08/2014

0

7,500

938,200

12/09/2014

0

8,500

929,700

Blocklisting return 30/09/2014

 

Long Term Incentive Plan ("LTIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

400,050

Blocklisting return 01/04/2014

30/09/2014

-

-

400,050

Blocklisting return 01/10/2014

 

 

Management Incentive Plan ("MIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

378,360

Blocklisting return 01/04/14

18/05/2014

0

261,480

116,880

12/06/2014

0

11,619

105,261

13/06/2014

0

77,487

27,774

30/06/2014

0

741

27,033

07/08/2014

0

2,856

24,177

22/08/2014

0

794

23,383

04/09/2014

0

300

23,083

12/09/2014

0

1,475

21,608

 Blocklisting return 01/10/14

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRKMMGGDVVGDZM
Date   Source Headline
10th Apr 20132:35 pmRNSAnnual Financial Report
5th Apr 201311:03 amRNSAnnual Information Update
5th Apr 201311:00 amRNSBlocklisting Interim Review
5th Apr 201310:53 amRNSTotal Voting Rights
25th Mar 20132:42 pmRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 201310:24 amRNSResponse to unsolicited enquiries
4th Feb 201310:29 amRNSHikma signs agreement with EffRx
21st Jan 201310:17 amRNSAdditional Listing
9th Jan 20137:00 amRNSAcquisition
3rd Jan 20133:55 pmRNSTotal Voting Rights
3rd Jan 20133:49 pmRNSNon Regulatory Announcement
27th Dec 20123:31 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSProduct Launch
27th Nov 20121:45 pmRNSBuilding Public Trust Awards - Highly Commended
12th Nov 20129:48 amRNSTotal Voting Rights
2nd Nov 20127:00 amRNSInterim Management Statement
1st Nov 201210:02 amRNSHolding(s) in Company
22nd Oct 201210:13 amRNSHikma & GP Pharm signs license & supply agreement
11th Oct 20121:00 pmRNSInjectables Analyst and Investor Day USA
10th Oct 201210:27 amRNSBlocklisting Interim Review
10th Oct 201210:06 amRNSTotal Voting Rights
4th Oct 20129:29 amRNSDividend Declaration
16th Aug 20127:00 amRNSHalf Yearly Report
8th Aug 201210:03 amRNSHolding(s) in Company
6th Jul 201212:24 pmRNSTotal Voting Rights
3rd Jul 20125:36 pmRNSHolding(s) in Company
29th Jun 201212:22 pmRNSDirector/PDMR Shareholding
25th Jun 201211:20 amRNSDirector/PDMR Shareholding
21st Jun 20123:04 pmRNSDirector/PDMR Shareholding
6th Jun 201211:34 amRNSTotal Voting Rights
18th May 201210:46 amRNSDirector/PDMR Shareholding
17th May 20123:27 pmRNSResult of AGM
17th May 20127:00 amRNSInterim Management Statement
1st May 20123:50 pmRNSHolding(s) in Company
20th Apr 201212:50 pmRNSHolding(s) in Company
16th Apr 20129:57 amRNSAnnual Information Update
13th Apr 201211:39 amRNSAnnual Financial Report & AGM Notice
4th Apr 20124:15 pmRNSCompany Secretary Change
2nd Apr 20125:21 pmRNSTotal Voting Rights
2nd Apr 20125:14 pmRNSBlocklisting Interim Review
28th Mar 201211:12 amRNSDirector/PDMR Shareholding
19th Mar 20124:52 pmRNSDirector/PDMR Shareholding
16th Mar 20123:22 pmRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSPreliminary Results
12th Mar 20127:00 amRNSHolding(s) in Company
14th Feb 20123:00 pmRNSTotal Voting Rights
2nd Feb 201211:14 amRNSHolding(s) in Company
1st Feb 20121:26 pmRNSDirector Declaration
17th Jan 201210:39 amRNSTender Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.